Oncotarget | Mivavotinib for Relapsed/Refractory B-cell Lymphoma (Updated)
“The current analysis provides updated results for these lymphoma patients with extended follow-up.” Credit: 2023 Gordon et al. “The current ...
Tag: Bcell
Oncotarget | Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001
“Taken together, these findings provide a strong rationale for potently and selectively targeting of CD74 in patients with B-NHL .” ...
Response-adapted ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B-cell lymphomas
ABSTRACT 3 Credit: MD Anderson Cancer Center ABSTRACT 3 SAN ANTONIO — Using a novel response-adapted ultra-low dose radiation therapy ...
New clinical trials from University Hospitals Seidman Cancer Center to begin with human protein following successful on-site approach to producing and using anti-CD19 CAR T cells against B-cell malignancies
CLEVELAND- Newly designed chimeric antigen receptor (CAR) T-cells targeting the CD19 antigen are effective in treating adults and children with ...
Ibrutinib improves survival for younger people with diffuse large B-cell lymphoma
New evidence suggests that adding the targeted therapy ibrutinib (Imbruvica) to a standard chemotherapy regimen can improve how long some ...
-
Spotted lanternfly spreads by hitching a ride with humans
-
Multi-state study reports COVID-19 mRNA vaccines protective during Omicron BA.4/BA.5 predominanc
-
The ACMG Foundation for Genetic and Genomic Medicine presents four Next Generation Fellowship Awards at the 2023 ACMG Annual Clinical Genetics Meeting
-
Genomic study of ancient humans sheds light on human evolution on the Tibetan Plateau
-
New study from Japan shows SARS-CoV-2 Omicron XBB.1.5 variant is highly transmissible and infectious
-
Cyprus’s copper deposits created one of the most important trade hubs in the Bronze Age